CPMG Inc
- SEC CIK
- 0001372218
- Latest filing
- May 15, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 15, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 5
- 0 vs. Q1 2022
- Portfolio value
- $497.8M
- −$98.4M (−16.5%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRCTPROCEPT BioRobotics Corp | COM | 10,918,393 | $356.9M | 71.7% | 00.0% | Unchanged | History |
| RETAReata Pharmaceuticals Inc | CL A | 2,896,901 | $88.0M | 17.7% | 00.0% | Unchanged | History |
| TILInstil Bio, Inc. | COM | 8,218,467 | $38.0M | 7.6% | 00.0% | Unchanged | History |
| APENApollo Endosurgery, Inc. | COM | 3,905,225 | $14.3M | 2.9% | 00.0% | Unchanged | History |
| iShares Tr464287622 | RUS 1000 ETF | 2,871 | $596.0K | 0.1% | +2,871 | New | – |
Sold out since Q1 2022 (1)
Positions held at the end of Q1 2022 that are gone from this filing.
| Security | Class | Shares in Q1 2022 | Value in Q1 2022 | % of portfolio in Q1 2022 | History |
|---|---|---|---|---|---|
| iShares S&P 500 Value ETF464287408 | ETF | 46,500 | $7.24M | 1.2% | – |